Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial.

Robert D LittleJo McKenzieAshish SrinivasanPatrick HilleyRobert B GilmoreDesmond CheeManjeet SandhuDaniel SaittaElizabeth ChowLena ThinGareth J WalkerGregory T MooreKate LynchJane AndrewsYoon K AnRobert V BryantSusan J ConnorMayur GargEmily K WrightGeorgina L HoldJonathan P SegalAlex BoussioutasPeter De CruzMark G WardMiles P Sparrow

Published in: BMJ open (2024)

ACTRN12622001458729.

Keyphrases

study protocol
randomized controlled trial
ulcerative colitis
high dose
clinical trial
double blind
cross sectional
low dose